English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51820195    在线人数 :  996
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"whang peng j"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 16-25 / 215 (共22頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-09-01T02:02:15Z Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏 2021-09-01T02:02:14Z Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J.
臺大學術典藏 2021-09-01T02:02:13Z Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.
臺大學術典藏 2021-09-01T02:02:13Z Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer Shiah H.-S.; ANN-LII CHENG; Hsu C.; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T.
臺大學術典藏 2021-09-01T01:54:18Z Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T.
臺大學術典藏 2021-09-01T01:54:14Z Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma Whang-Peng J.; ANN-LII CHENG; Hsu C.; Chen C.-M.
臺大學術典藏 2021-09-01T01:54:08Z A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; Yeh K.-H.; Chen L.-T.; Whang-Peng J.
臺大學術典藏 2021-09-01T01:54:05Z Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.
臺大學術典藏 2021-09-01T01:53:54Z The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme Lee P.-Y.; Chen C.-L.; Lin Z.-Z.; ANN-LII CHENG; Chen E.I.-T.; Whang-Peng J.; Huang C.-Y.F.
臺大學術典藏 2021-08-31T06:29:42Z A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung Liu K.-J.; Chao T.-Y.; Chang J.-Y.; ANN-LII CHENG; Ch'Ang H.-J.; Kao W.-Y.; Wu Y.-C.; Yu W.-L.; Chung T.-R.; Whang-Peng J.

顯示項目 16-25 / 215 (共22頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目